Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1895655

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1895655

Global Cerebral Oximetry Monitoring Market Growth, Size, Trends Analysis - By Age Group, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

PUBLISHED:
PAGES: 259 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Global Cerebral Oximetry Monitoring Market Introduction and Overview

According to SPER Market Research, the Global Cerebral Oximetry Monitoring Market is estimated to reach USD 473.45 million by 2034 with a CAGR of 6.98%.

The report includes an in-depth analysis of the Global Cerebral Oximetry Monitoring Market, including market size and trends, product mix, Applications, and supplier analysis. The Global Cerebral Oximetry Monitoring Market was valued at USD 241.13 million in 2024, and it is expected to rise at a 6.98% CAGR from 2025 to 2034. Rising neurological illnesses, technological developments in accurate and portable equipment, a greater emphasis on patient safety, and the expanding use of non-invasive brain monitoring are all driving demand for cerebral oximetry monitoring. Expanding cardiovascular and neurosurgery treatments, combined with an aging population, drive up demand. Meanwhile, adoption of cerebral oximetry monitoring is hampered by measurement uncertainty, expensive equipment prices, and a scarcity of skilled personnel. Additional hurdles include connecting devices with current systems and continuous maintenance requirements, which collectively limit accessibility, impair clinical confidence, and hinder general adoption across healthcare facilities.

By Age Group Insights

The global cerebral oximetry monitoring market is separated into two age groups are adults and children, with adults leading in adoption. The rising occurrence of age-related ailments, such as cardiovascular disease, neurological disorders, and other surgical difficulties, highlights the importance of constant brain oxygen monitoring. Cerebral oximetry ensures proper oxygenation during essential procedures, which improves patient safety and outcomes. Furthermore, the increasing licensing and clearance of innovative technologies for adult patients drives up adoption. Because of an older population, increased surgical procedures, and technological developments in monitoring equipment, the adult segment has emerged as the main and fastest-growing user group in cerebral oximetry.

By Application Insights

The global cerebral oximetry monitoring market is divided into three segments based on application are cardiac surgery, vascular surgery, and other operations, with cardiac surgery leading in adoption. Cerebral oximeters are crucial for monitoring brain oxygen levels during cardiac surgery, assuring patient safety and reducing neurological problems. The increasing number of open-heart and sophisticated cardiac surgeries worldwide necessitates precise brain oxygen monitoring. As hospitals and surgical centers execute more complex cardiac procedures, the demand for cerebral oximetry devices is likely to increase. Their use improves surgical results, real-time decision-making, and overall patient care in high-risk cardiac procedures.

By End User Insights

Based on the end user, cerebral oximetry monitoring is used in hospitals, ambulatory surgery centers, and other healthcare institutions, with hospitals leading the way. Hospitals use these devices to improve patient safety, manage neurological deficits, and provide better care, particularly during high-risk procedures and surgeries. Patients increasingly demand facilities with advanced monitoring systems, whereas specialists use cerebral oximeters in operating rooms and intensive care units to monitor brain oxygen levels. Hospitals' dominant position is driven by the availability of professional care, improved treatments, and critical care services, with increasing hospital and clinic visits enabling wider use and growth of cerebral oximetry monitoring.

Regional Insights

The United States dominates the cerebral oximetry monitoring sector because to its expanding older population, high prevalence of neurological illnesses, and advanced healthcare infrastructure. The widespread use of coronary artery bypass surgery, as well as an increase in Alzheimer's cases, highlight the importance of monitoring brain oxygen levels. Additionally, research funding for disorders such as cerebral palsy encourages the use of cerebral oximeters for routine oxygen monitoring. The strong presence of significant industry players, as well as ongoing technical developments, all help to drive growth. These elements combine to generate prospects for the development of enhanced cerebral oximeters, establishing the United States as a key region for market expansion and acceptance of sophisticated brain monitoring technologies.

Market Competitive Landscape

The cerebral oximetry monitoring industry is moderately concentrated, with a few key players dominating the market. Major corporations have acquired strong positions in certain areas, battling with both domestic and foreign firms in emerging markets. To remain competitive, these companies are focusing on creating and deploying new technology and improved products. Strategic collaborations, acquisitions, and partnerships with other market actors are also being pursued to improve capabilities and broaden reach. Masimo, Edwards Lifesciences, Medtronic PLC, Nonin Medical Inc, ISS Inc, GE Healthcare Inc, Koninklijke Philips NV, and Mespere LifeSciences are among the key firms driving this trend, influencing the industry's growth and innovation landscape.

Recent Developments:

Masimo introduced the next-generation O3A(R) system in late 2023, which includes AI-driven desaturation prediction and adaptive thresholding tailored to individual patient baselines. Additionally, the platform offers enhanced integration with hospital EMRs through the Root monitoring hub.

In 2024, Medtronic broadened its BIS monitoring platform by adding a cerebral oximetry module specifically engineered for off-pump cardiac surgeries and pediatric bypass procedures.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Age Group, By Application, By End User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered CASMED, Edwards, GE HealthCare, HAMAMATSU, Honeywell, Masimo, Medtronic, Mespere LIFE SCIENCES, mindray, NIHON KOHDEN.

Key Topics Covered in the Report

Global Cerebral Oximetry Monitoring Market Size (FY'2021-FY'2034)

Overview of Global Cerebral Oximetry Monitoring Market

Segmentation of Global Cerebral Oximetry Monitoring Market By Age Group (Adult, Pediatric)

Segmentation of Global Cerebral Oximetry Monitoring Market By Application (Cardiac surgery, Vascular surgery, other applications)

Segmentation of Global Cerebral Oximetry Monitoring Market By End User (Hospitals, Ambulatory surgical centers, Other end user)

Statistical Snap of Global Cerebral Oximetry Monitoring Market

Expansion Analysis of Global Cerebral Oximetry Monitoring Market

Problems and Obstacles in Global Cerebral Oximetry Monitoring Market

Competitive Landscape in the Global Cerebral Oximetry Monitoring Market

Details on Current Investment in Global Cerebral Oximetry Monitoring Market

Competitive Analysis of Global Cerebral Oximetry Monitoring Market

Prominent Players in the Global Cerebral Oximetry Monitoring Market

SWOT Analysis of Global Cerebral Oximetry Monitoring Market

Global Cerebral Oximetry Monitoring Market Future Outlook and Projections (FY'2025-FY'2034)

Recommendations from Analyst

Product Code: MEDE2574

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Cerebral Oximetry Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cerebral Oximetry Monitoring Market

7.Global Cerebral Oximetry Monitoring Market, By Age Group (USD Million) 2021-2034

  • 7.1.Adult
  • 7.2.Pediatric

8.Global Cerebral Oximetry Monitoring Market, By Application (USD Million) 2021-2034

  • 8.1.Cardiac surgery
  • 8.2.Vascular surgery
  • 8.3.Others

9.Global Cerebral Oximetry Monitoring Market, By End User (USD Million) 2021-2034

  • 9.1.Hospitals
  • 9.2.Ambulatory surgical centers
  • 9.3.Others

10.Global Cerebral Oximetry Monitoring Market, (USD Million) 2021-2034

  • 10.1.Global Cerebral Oximetry Monitoring Market Size and Market Share

11.Global Cerebral Oximetry Monitoring Market, By Region, (USD Million) 2021-2034

  • 11.1.Asia-Pacific
    • 11.1.1.Australia
    • 11.1.2.China
    • 11.1.3.India
    • 11.1.4.Japan
    • 11.1.5.South Korea
    • 11.1.6.Rest of Asia-Pacific
  • 11.2.Europe
    • 11.2.1.France
    • 11.2.2.Germany
    • 11.2.3.Italy
    • 11.2.4.Spain
    • 11.2.5.United Kingdom
    • 11.2.6.Rest of Europe
  • 11.3.Middle East and Africa
    • 11.3.1.Kingdom of Saudi Arabia
    • 11.3.2.United Arab Emirates
    • 11.3.3.Qatar
    • 11.3.4.South Africa
    • 11.3.5.Egypt
    • 11.3.6.Morocco
    • 11.3.7.Nigeria
    • 11.3.8.Rest of Middle-East and Africa
  • 11.4.North America
    • 11.4.1.Canada
    • 11.4.2.Mexico
    • 11.4.3.United States
  • 11.5.Latin America
    • 11.5.1.Argentina
    • 11.5.2.Brazil
    • 11.5.3.Rest of Latin America

12.Company Profile

  • 12.1.CASMED
    • 12.1.1.Company details
    • 12.1.2.Financial outlook
    • 12.1.3.Product summary
    • 12.1.4.Recent developments
  • 12.2.Edwards
    • 12.2.1.Company details
    • 12.2.2.Financial outlook
    • 12.2.3.Product summary
    • 12.2.4.Recent developments
  • 12.3.GE HealthCare
    • 12.3.1.Company details
    • 12.3.2.Financial outlook
    • 12.3.3.Product summary
    • 12.3.4.Recent developments
  • 12.4.HAMAMATSU
    • 12.4.1.Company details
    • 12.4.2.Financial outlook
    • 12.4.3.Product summary
    • 12.4.4.Recent developments
  • 12.5.Honeywell
    • 12.5.1.Company details
    • 12.5.2.Financial outlook
    • 12.5.3.Product summary
    • 12.5.4.Recent developments
  • 12.6.Masimo
    • 12.6.1.Company details
    • 12.6.2.Financial outlook
    • 12.6.3.Product summary
    • 12.6.4.Recent developments
  • 12.7.Medtronic
    • 12.7.1.Company details
    • 12.7.2.Financial outlook
    • 12.7.3.Product summary
    • 12.7.4.Recent developments
  • 12.8.Mespere LIFE SCIENCES
    • 12.8.1.Company details
    • 12.8.2.Financial outlook
    • 12.8.3.Product summary
    • 12.8.4.Recent developments
  • 12.9.mindray
    • 12.9.1.Company details
    • 12.9.2.Financial outlook
    • 12.9.3.Product summary
    • 12.9.4.Recent developments
  • 12.10.NIHON KOHDEN
    • 12.10.1.Company details
    • 12.10.2.Financial outlook
    • 12.10.3.Product summary
    • 12.10.4.Recent developments
  • 12.11.Others

13.Conclusion

14.List of Abbreviations

15.Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!